Viral vectors are a key component of many advanced gene therapies and vaccines, but reliable, large-scale manufacturing remains a significant challenge. Continued innovation in vector design, cell ...
NanoMosaic's technology is designed to support upstream and downstream process development, quality control, and release testing.
As climate change extends mosquito habitats and vector-borne diseases remain a critical concern, industry analysis suggests ...
AGC Biologics signed a licensing agreement to use Asimov’s lentiviral packaging system, enabling production from a single-plasmid transfection.
Non-specific Endonuclease Market to reach US$ 726.6 Bn by 2036 at 6.5% CAGR, driven by rising biotechnology research, ...
Asimov, the synthetic biology company advancing the design and manufacture of therapeutics, and AGC Biologics, your friendly CDMO expert, have signed a licensing agreement for Asimov’s off-the-shelf ...
The FDA AMT designation verifies NanoMosaic platform's ability to enhance efficiency, product quality, and scalability across AAV gene therapy manufacturing.
In every Christopher King bag there are lessons about quality and about pride in one’s work. This founder is someone who puts ...
AskBio Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, recently announced that the United States Food and Drug Administration (FDA) has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results